Tu1348 Biosimilar Infliximab in Inflammatory Bowel Diseases: First Interim Results From a Prospective Nationwide Observational Cohort
暂无分享,去创建一个
K. Farkas | T. Molnár | M. Papp | P. Lakatos | Z. Szepes | P. Miheller | J. Banai | K. Gecse | L. Lakatos | K. Palatka | T. Szamosi | Á. Vincze | P. Golovics | B. Lovász | T. Kristof